Large-scale testing (Phase 3)UnknownNCT01654146What this trial is testingICON8: Weekly Chemotherapy in Ovarian CancerWho this might be right forOvarian Cancer Medical Research Council 1,485
Testing effectiveness (Phase 2)Study completedNCT00003670What this trial is testingHormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal CancerWho this might be right forOvarian CancerPrimary Peritoneal Cavity Cancer Eli Lilly and Company
Early research (Phase 1)Study completedNCT00616941What this trial is testingPhase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer Ludwig Institute for Cancer Research 28
Early research (Phase 1)Study completedNCT03629756What this trial is testingEvaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesWho this might be right forNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more Arcus Biosciences, Inc. 48
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Testing effectiveness (Phase 2)Ended earlyNCT00516841What this trial is testingA Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal CancerWho this might be right forOvarian CancerPeritoneal Neoplasms Facet Biotech 16
Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Very early researchUnknownNCT05180851What this trial is testingSafety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical StudyWho this might be right forHead and Neck CancerMelanomaBreast Cancer+4 more Shanghai Fengxian District Central Hospital 28
Early research (Phase 1)Study completedNCT01665183What this trial is testingPh 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic MelanomaWho this might be right forCutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors Polaris Group 8
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816666What this trial is testingTorvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian CancerWho this might be right forPlatinum-sensitive Relapsed Epithelial Ovarian CancerPlatinum-sensitive Relapsed Fallopian Tube CancerPlatinum-sensitive Relapsed Primary Peritoneal Cancer AstraZeneca 600
Early research (Phase 1)Active Not RecruitingNCT07038369What this trial is testingATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsWho this might be right forAdvanced Solid TumorsBreast CancerBreast Carcinoma+24 more Atavistik Bio, Inc 134
Testing effectiveness (Phase 2)Study completedNCT02324595What this trial is testingMinimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility StudyWho this might be right forStage IV Ovarian CarcinomaEffects of ChemotherapyPeritoneal Cavity Cancer Catholic University of the Sacred Heart 30
Testing effectiveness (Phase 2)Study completedNCT00017017What this trial is testingCT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01264432What this trial is testingVeliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal CancerWho this might be right forAdult Solid NeoplasmPeritoneal CarcinomatosisRecurrent Fallopian Tube Carcinoma+2 more National Cancer Institute (NCI) 34
Early research (Phase 1)Active Not RecruitingNCT05075993What this trial is testingStudy of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsWho this might be right forMetastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more M.D. Anderson Cancer Center 352
Large-scale testing (Phase 3)UnknownNCT00002477What this trial is testingAdjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial CancerWho this might be right forOvarian Cancer Medical Research Council
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT02728492What this trial is testingSafety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With ChemotherapyWho this might be right forNon-small Cell Lung CancerEpithelial Ovarian Cancer NewVac LLC 51
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06128551What this trial is testingStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma Revolution Medicines, Inc. 534